Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New treatments for alopecia areata focus on targeting immune responses for better results.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

New understanding and treatments for hair loss are improving, but more research is needed.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Regenerative medicine is effective and safe for treating vitiligo.

No single treatment is clearly effective for central serous chorioretinopathy.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Dupilumab effectively treated severe alopecia areata in a child.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Satoyoshi syndrome is likely an autoimmune disease.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Pericardiocentesis and immunosuppressants effectively treat cardiac tamponade in pregnant women with SLE.